Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period.
The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$292.8 million in the December quarter from C$1.30 billion in the second quarter of 2020. The improvement reflects a 23% year-over-year increase in revenues to C$67.67 million.
Shares of Aurora Cannabis declined soon after the earnings release on Thursday evening at the New York Stock Exchange, after closing the session down 23%.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and
It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied
Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the